Arca Biopharma | ABIO - Des Atouts

Prix De L'Action
41.25
Variation Quotidienne
2.34 6.01%
Mensuellement
16.00%
Annuel
233.74%
Q1 Prévisions
37.74




Des Atouts Changement Date
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amgen USD 90.59B 445M 2025-12
Arca Biopharma USD 488.62M 20.63M 2025-12
Biogen USD 29.44B 232M 2025-12
Brainstorm Cell Therapeutics USD 1.38M 1.19M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Capricor Therapeutics USD 355.95M 229.51M 2025-12
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.42B 12.02M 2025-12
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
Otsuka Holdings JPY 4.2T 238.02B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
United Therapeutics USD 7.88B 528.9M 2025-12